Thomas R Staab II
Chief Financial Officer · 3 filings · Latest: May 11, 2026
LENSAR, Inc.
TENAX THERAPEUTICS, INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
TENX | Thomas R Staab II | Chief Financial Officer | May 11, 2026 | Grant/Award | $0.00 | 10,000 | — | 10,000 | |
LNSR | Thomas R Staab II | Chief Financial Officer | May 6, 2026 | Tax Withholding | $5.39 | 1,350 | $7.3K | 174,609 | |
LNSR | Thomas R Staab II | Chief Financial Officer | Mar 19, 2026 | Option Exercise | $2.65 | 5,500 | $14.6K | 175,959 |